Short-term treatment, maintenance therapy after recovery of active gastric, duodenal ulcer. Symptomatic relief of reflux esophagitis. Pathologic hypersecretory state (eg, Zollinger-Ellison syndrome & systemic mastocytosis).
Dosage/Direction for Use
AdultActive duodenal ulcer 150 mg twice daily or 300 mg once daily for 4-8 wk. Active gastric ulcer 150 mg twice daily for 2 wk. Maintenance therapy after recovery of duodenal/peptic ulcer 150 mg. Zollinger-Ellison syndrome & systemic mastocytosis 150 mg twice daily. Max: 6 g. GERD 150 mg twice daily. Chronic esophagitis 150 mg 4 times daily. Maintenance & recovery of abrasive esophagitis 150 mg twice daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Special Precautions
Symptomatic response does not prevent onset of gastric malignancy. Pregnancy & lactation.
A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Bloxer FC tab 150 mg
Packing/Price
10 × 10's (Rp45,800/pak)
Form
Bloxer FC tab 300 mg
Packing/Price
10 × 10's (Rp78,000/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
